Key Market Indicators
By 2026, the prevalence of HIV/AIDS among children aged 0-14 in Central Africa is projected to drop to 3,500 from 5,450 in 2021, a decrease of 7.5% each year on average since 1995. In 2021, Central Africa ranked 34th in prevalence, with Botswana surpassing it at 5,450. Nigeria, Mozambique and Tanzania were the second, third and fourth most affected countries in this ranking. The coverage of treatment among people living with HIV in Central Africa is expected to reach 76% by 2026, up from 60% in 2021, with an average annual growth rate of 3.8%. Since 2010, the market has grown by 12.7% each year. In 2021, Central Africa was ranked 80th in treatment coverage, with Slovakia coming in at 60%. Cape Verde, Latvia and Zimbabwe took the second, third and fourth spots.
